By: June Chen, MD
Proton-pump inhibitors (PPI), often used to treat heartburn, are a group of drugs whose main action is a significant and long-lasting reduction of acid production in the stomach. However, according to a study published in the July 2009 issue of Gastroenterology, stopping PPI therapy may actually cause rebound hypersecretion of acid.
Researchers from Copenhagen University in Copenhagen, Denmark studied 120 healthy volunteers who were randomized to receive either the PPI esomeprazole or a placebo pill for 8 weeks, followed by 4 weeks of placebo. They found that, among study participants who received esomeprazole, 44% reported at least 1 acid-related symptom, including heartburn, acid reflux, or dyspepsia, in weeks 9 to 12 of the study, as compared to only 15% in the placebo group.
Gastroenterology. 2009;137:20-39.